June 23, 2025

Blood Biomarker Identified for Early GVHD Risk

Soluble MICA levels before and during engraftment identified high GVHD risk after stem cell transplant

The Pathologist

July 18, 2025

Tislelizumab Outcomes Linked to PD-L1 Method

Researchers compare Tumor Area Positivity score and Combined Positive Score for programmed death-ligand 1 expression in gastric and esophageal cancers

The Pathologist

August 08, 2025

Digital Twin Technology for Clinical Pathology

Real-time virtual models could help improve efficiency, reduce errors, and assist in diagnostic decision-making

The Pathologist

August 08, 2025

Phase III Data on Bausch + Lomb's LUMIFY®

Publication of phase III data on LUMIFY® preservative-free redness reliever eye drops

The Ophthalmologist

August 08, 2025

Also in the News…

The Ophthalmologist brings you the top news stories and studies of the week

The Ophthalmologist

August 07, 2025

DREAMM-7 Analysis Compares Survival Outcomes Between Triplet Regimens for Relapsed or Refractory Multiple Myeloma

In an analysis from the phase III DREAMM-7 trial reported in The Lancet Oncology, Hungria et al compared survival outcomes with belantamab mafodotin, bortezomib, and dexamethasone vs daratumumab, bort...

The ASCO Post

August 07, 2025

Introducing Mass Spectrometry Histochemistry

Pathology’s future lies in unlocking the molecular signals preserved in FFPE tissue

The Pathologist

August 07, 2025

Metagenomics Reshapes Intensive Care Units

UK hospitals are using real-time sequencing to detect infections faster, improve patient outcomes, and support national surveillance

The Pathologist

August 07, 2025

Laser-Induced Polymer Fragmentation in IOLs

Nd:YAG lasers are powerful tools — but let’s use them like surgeons, not like Terminators

The Ophthalmologist